Tech Company Financing Transactions
Cellino Funding Round
Cellino, based in Cambridge, received $16 million from Khosla Ventures, The Engine and 8VC.
Transaction Overview
Company Name
Announced On
2/2/2021
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to automate and scale its AI-based personalized tissue and cell platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
501 Mass Ave.
Cambridge, MA 20139
USA
Cambridge, MA 20139
USA
Phone
Undisclosed
Website
Email Address
Overview
Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson's, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures for these indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nabiha Saklayen
Chief Financial Officer
Julie Andriolo
Chief Technical Officer
Matthias Wagner
VP - Engineering
Steven Nagle
VP - Product Management
Marinna Madrid
Browse more venture capital transactions:
Prev: 2/2/2021: SightGain venture capital transaction
Next: 2/2/2021: UiPath venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs